Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1375 of 1467 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/17/17
End: 07/05/17
Due: 07/05/18
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 11/30/02
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 07/31/02
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 02/06/13
End: 06/20/23
Due: 06/20/24
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 01/31/03
End: 05/31/04
Due: 05/31/05
Phase: N/A
Priority: Normal
Start: 07/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/09/21
End: 06/23/23
Due: 06/23/24
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 07/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 06/09/22
End: 11/17/26
Due: 11/17/27
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
Phase: N/A
Priority: Normal
Start: 08/28/12
End: 07/11/24
Due: 07/11/25
Phase: N/A
Priority: Normal
Start: 08/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/03
End: 01/31/05
Due: 01/31/06
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 08/10/27
Due: 08/10/28
Phase: N/A
Priority: Normal
Start: 11/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 06/03/25
End: 10/17/29
Due: 10/17/30